• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

索马帕坦(somapacitan),一种长效生长激素衍生物的组织分布和受体激活。

Tissue Distribution and Receptor Activation by Somapacitan, a Long Acting Growth Hormone Derivative.

机构信息

Global Drug Discovery, Novo Nordisk A/S, 2760 Måløv, Denmark.

Global Research Technologies, Novo Nordisk A/S, 2760 Måløv, Denmark.

出版信息

Int J Mol Sci. 2020 Feb 11;21(4):1181. doi: 10.3390/ijms21041181.

DOI:10.3390/ijms21041181
PMID:32053994
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7072805/
Abstract

Somapacitan is a long-acting, once-weekly, albumin-binding growth hormone (GH) derivative. The reversible albumin-binding properties leads to prolonged circulation half-life. Here, we investigated and compared somapacitan with human GH on downstream receptor signaling in primary hepatocytes and hepatocellular models and using isothermal titration calorimetry to characterize receptor binding of somapacitan in the presence or absence of human serum albumin (HSA). With non-invasive fluorescence imaging we quantitatively visualize and compare the temporal distribution and examine the tissue-specific growth hormone receptor (GHR) activation at distribution sites. We found that signaling kinetics were slightly more rapid and intense for GH compared with somapacitan. Receptor binding isotherms were characterized by a high and a low affinity interaction site with or without HSA. Using in vivo optical imaging we found prolonged systemically biodistribution of somapacitan compared with GH, which correlated with plasma pharmacokinetics. Ex vivo mouse organ analysis revealed that the temporal fluorescent intensity in livers dosed with somapacitan was significantly increased compared with GH-dosed livers and correlated with the degree of downstream GHR activation. Finally, we show that fluorescent-labeled analogs distributed to the hypertrophic zone in the epiphysis of proximal tibia of hypophysectomized rats and that somapacitan and GH activate the GHR signaling in epiphyseal tissues.

摘要

索马帕肽是一种长效、每周一次、白蛋白结合型生长激素(GH)衍生物。其可逆的白蛋白结合特性导致其循环半衰期延长。在这里,我们研究并比较了索马帕肽和人 GH 对原代肝细胞和肝细胞模型下游受体信号的影响,并使用等温滴定量热法来表征索马帕肽在存在或不存在人血清白蛋白(HSA)时与受体的结合。我们通过非侵入性荧光成像技术定量可视化和比较了时空分布,并检查了在分布部位的组织特异性生长激素受体(GHR)的激活情况。我们发现,与索马帕肽相比,GH 的信号转导动力学稍快且强度更高。受体结合等温线的特征是存在或不存在 HSA 时具有高亲和力和低亲和力相互作用位点。使用体内光学成像,我们发现与 GH 相比,索马帕肽在体内的系统生物分布时间更长,这与血浆药代动力学相关。离体小鼠器官分析显示,与 GH 处理的肝脏相比,索马帕肽处理的肝脏中荧光强度在时间上显著增加,并且与下游 GHR 激活的程度相关。最后,我们表明,荧光标记的类似物分布到去垂体大鼠近端胫骨骺板的肥大区,并且索马帕肽和 GH 激活骺板组织中的 GHR 信号。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56e5/7072805/62e175349081/ijms-21-01181-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56e5/7072805/57744aeb7bff/ijms-21-01181-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56e5/7072805/09e0b7d5efb4/ijms-21-01181-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56e5/7072805/0e95f3cd1fe1/ijms-21-01181-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56e5/7072805/d7f8cc44a238/ijms-21-01181-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56e5/7072805/b9a3053a645e/ijms-21-01181-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56e5/7072805/62e175349081/ijms-21-01181-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56e5/7072805/57744aeb7bff/ijms-21-01181-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56e5/7072805/09e0b7d5efb4/ijms-21-01181-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56e5/7072805/0e95f3cd1fe1/ijms-21-01181-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56e5/7072805/d7f8cc44a238/ijms-21-01181-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56e5/7072805/b9a3053a645e/ijms-21-01181-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56e5/7072805/62e175349081/ijms-21-01181-g006.jpg

相似文献

1
Tissue Distribution and Receptor Activation by Somapacitan, a Long Acting Growth Hormone Derivative.索马帕坦(somapacitan),一种长效生长激素衍生物的组织分布和受体激活。
Int J Mol Sci. 2020 Feb 11;21(4):1181. doi: 10.3390/ijms21041181.
2
Somapacitan, a once-weekly reversible albumin-binding GH derivative, in children with GH deficiency: A randomized dose-escalation trial.索马帕坦,一种每周一次的可还原白蛋白结合型 GH 衍生物,用于治疗儿童生长激素缺乏症:一项随机剂量递增试验。
Clin Endocrinol (Oxf). 2017 Oct;87(4):350-358. doi: 10.1111/cen.13409. Epub 2017 Aug 8.
3
Nonclinical pharmacokinetic and pharmacodynamic characterisation of somapacitan: A reversible non-covalent albumin-binding growth hormone.索马帕西坦的非临床药代动力学和药效学特征:一种可逆的非共价结合白蛋白的生长激素。
Growth Horm IGF Res. 2017 Aug;35:8-16. doi: 10.1016/j.ghir.2017.05.006. Epub 2017 May 24.
4
Identification of Binding Sites on Human Serum Albumin for Somapacitan, a Long-Acting Growth Hormone Derivative.鉴定长效人生长激素类似物索马帕坦与人血清白蛋白的结合位点。
Biochemistry. 2020 Apr 14;59(14):1410-1419. doi: 10.1021/acs.biochem.0c00019. Epub 2020 Mar 30.
5
Absorption, metabolism and excretion of once-weekly somapacitan, a long-acting growth hormone derivative, after single subcutaneous dosing in human subjects.单次皮下给予长效生长激素类似物索马帕肽后,在人体中的吸收、代谢和排泄。
Eur J Pharm Sci. 2021 Dec 1;167:106030. doi: 10.1016/j.ejps.2021.106030. Epub 2021 Oct 1.
6
Once-Weekly Somapacitan vs Daily GH in Children With GH Deficiency: Results From a Randomized Phase 2 Trial.每周一次的索马帕肽与每日生长激素治疗生长激素缺乏症儿童:一项随机 2 期试验结果。
J Clin Endocrinol Metab. 2020 Apr 1;105(4):e1847-61. doi: 10.1210/clinem/dgz310.
7
Utilizing Somapacitan, a Long-acting Growth Hormone Formulation, for the Treatment of Adult Growth Hormone Deficiency: A Guide for Clinicians.使用长效生长激素制剂索马帕西坦治疗成人生长激素缺乏症:临床医生指南
Endocr Pract. 2024 Oct;30(10):1003-1010. doi: 10.1016/j.eprac.2024.07.003. Epub 2024 Jul 9.
8
Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trial.每周一次索马帕坦治疗成人生长激素缺乏症的安全性和便利性:26 周随机对照试验。
Eur J Endocrinol. 2018 May;178(5):491-499. doi: 10.1530/EJE-17-1073. Epub 2018 Mar 2.
9
Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial.每周一次索马帕肽治疗成人生长激素缺乏症的有效性和耐受性:一项随机 3 期试验。
J Clin Endocrinol Metab. 2020 Apr 1;105(4):e1358-76. doi: 10.1210/clinem/dgaa049.
10
Similar safety and efficacy in previously treated adults with growth hormone deficiency randomized to once-weekly somapacitan or daily growth hormone.在先前接受过治疗的生长激素缺乏症成人患者中,每周一次somapacitan 或每日生长激素的随机安全性和疗效相似。
Clin Endocrinol (Oxf). 2020 Nov;93(5):620-628. doi: 10.1111/cen.14273. Epub 2020 Aug 14.

引用本文的文献

1
Long-Acting Growth Hormone for Pediatric Growth Hormone Deficiency.用于儿童生长激素缺乏症的长效生长激素
J Endocr Soc. 2025 Mar 4;9(5):bvaf040. doi: 10.1210/jendso/bvaf040. eCollection 2025 May.
2
Developments in the Management of Growth Hormone Deficiency: Clinical Utility of Somapacitan.生长激素缺乏症管理的进展:索马帕西坦的临床应用
Drug Des Devel Ther. 2024 Feb 3;18:291-306. doi: 10.2147/DDDT.S315172. eCollection 2024.

本文引用的文献

1
The effects of growth hormone on adipose tissue: old observations, new mechanisms.生长激素对脂肪组织的影响:旧观察,新机制。
Nat Rev Endocrinol. 2020 Mar;16(3):135-146. doi: 10.1038/s41574-019-0280-9. Epub 2019 Nov 28.
2
Targeting growth hormone function: strategies and therapeutic applications.靶向生长激素功能:策略与治疗应用。
Signal Transduct Target Ther. 2019 Feb 8;4:3. doi: 10.1038/s41392-019-0036-y. eCollection 2019.
3
Long-Acting Human Growth Hormone Analogue by Noncovalent Albumin Binding.长效型人人生长激素类似物通过非共价白蛋白结合。
Bioconjug Chem. 2018 Sep 19;29(9):3129-3143. doi: 10.1021/acs.bioconjchem.8b00463. Epub 2018 Aug 31.
4
THERAPY OF ENDOCRINE DISEASE: Growth hormone replacement therapy in adults: 30 years of personal clinical experience.内分泌疾病治疗学:成人生长激素替代疗法:30 年的个人临床经验。
Eur J Endocrinol. 2018 Jul;179(1):R47-R56. doi: 10.1530/EJE-18-0306. Epub 2018 May 1.
5
The Growth Hormone Receptor: Mechanism of Receptor Activation, Cell Signaling, and Physiological Aspects.生长激素受体:受体激活机制、细胞信号传导及生理学方面
Front Endocrinol (Lausanne). 2018 Feb 13;9:35. doi: 10.3389/fendo.2018.00035. eCollection 2018.
6
Nonclinical pharmacokinetic and pharmacodynamic characterisation of somapacitan: A reversible non-covalent albumin-binding growth hormone.索马帕西坦的非临床药代动力学和药效学特征:一种可逆的非共价结合白蛋白的生长激素。
Growth Horm IGF Res. 2017 Aug;35:8-16. doi: 10.1016/j.ghir.2017.05.006. Epub 2017 May 24.
7
Disruption of the GH Receptor Gene in Adult Mice Increases Maximal Lifespan in Females.成年小鼠生长激素受体基因的破坏可延长雌性小鼠的最大寿命。
Endocrinology. 2016 Dec;157(12):4502-4513. doi: 10.1210/en.2016-1649. Epub 2016 Oct 12.
8
The kidneys play a central role in the clearance of rhGH in rats.肾脏在大鼠生长激素(rhGH)的清除过程中起核心作用。
Eur J Pharm Sci. 2016 Apr 30;86:29-33. doi: 10.1016/j.ejps.2016.02.019. Epub 2016 Mar 2.
9
Translational mixed-effects PKPD modelling of recombinant human growth hormone - from hypophysectomized rat to patients.重组人生长激素的转化混合效应药代动力学-药效学建模——从垂体切除大鼠到患者
Br J Pharmacol. 2016 Jun;173(11):1742-55. doi: 10.1111/bph.13473. Epub 2016 Apr 21.
10
Adherence to growth hormone therapy: results of a multicenter study.生长激素治疗的依从性:一项多中心研究的结果。
Endocr Pract. 2014 Jan;20(1):46-51. doi: 10.4158/EP13194.OR.